Participated · Series D · Aug 2022

VidMob provides an end-to-end Intelligent Creative platform to help brands produce, track, measure, score and optimize the performance of their creative advertising across major digital advertising platforms. Its platform integrates with channels including Google, Meta, Amazon Ads, TikTok, LinkedIn, Twitter, Snap, Pinterest, Hulu and Reddit. Led by CEO and Co-Founder Alex Collmer, the company highlights the breadth of its solution. VidMob raised $110m in a Series D funding round. The company will use the funding to continue to invest in sales and marketing, accelerate platform development and expand its global presence. VidMob is based in London, UK. VidMob operates the Intelligent Creative platform, which uses AI to measure creative performance and unifies creative and data to help marketers optimize ad design. The platform connects brands to a global network of elite content creators trained on best practices for digital channels and next‑gen ad formats. Originally focused on major social platforms, VidMob has expanded distribution into the programmatic web and CTV/OTT. The company says it will use new capital to support global expansion, new e-commerce initiatives, and ongoing investments in advanced technology and data science. VidMob counts clients including Johnson & Johnson and Colgate Palmolive and highlights certifications as a creative partner across major social and digital platforms. A portion of revenue funds its 501(c)(3) VidMob Gives, which has supported 84 nonprofit organizations across 63 countries. VidMob began as a marketplace connecting marketers with professional video editors, animators and designers and has expanded into a broader product called the Agile Creative Studio. The platform lets marketers find talent and, with a single click, send hundreds or thousands of custom ads to partners like Facebook, Google/YouTube, Instagram, Snapchat and Twitter. VidMob analyzes how different creative elements affect audience response and uses that data to iteratively improve campaign performance; the CEO says the decay curve can invert as ads improve over time. Brands using VidMob include Bayer, InterContinental Hotels Group, Ikea, Neutrogena and startups like Acorns. The company has raised $25 million in a Series B and more than $45 million in total funding. Founder and CEO Alex Collmer describes a vision of VidMob as an "API for creativity" that could expand beyond social video into future media types such as augmented reality. VidMob is a video creation platform that combines proprietary technology and a network of trained creators to develop insight-driven, personalized, and scalable marketing video content across social and digital channels. Founded in 2014 and led by CEO Alex Collmer, the company produces video content across every channel, format and language. VidMob serves global brand clients including InterContinental Hotel Group, Mondelez and BMW, and works with agency partners such as Mindshare, Wavemaker and Universal McCann. The company recently opened a London office and plans to use new capital to support continued international growth and to expand its creative insights platform. VidMob has now raised $20m in total funding after an additional extension to its Series A round. VidMob is a New York-based video creation platform and network that connects brands and advertisers with a global network of professional creatives. Clients use VidMob to collaborate with expert creatives to develop suites of video assets optimized for every digital channel. The company, led by founder and CEO Alex Collmer, operates offices in Los Angeles, New York, Chicago and Massachusetts. VidMob plans to use the Series A proceeds to grow headcount across its four offices, expand technology capacity and tools, and deepen agency and brand partnerships. Earlier in 2017 the company was awarded official marketing partner badges by Facebook and Snap and won innovation awards from Instagram and Twitter for its creative solutions. VidMob has raised more than $13m in total since its 2015 founding.

Participated · Series C · Oct 2020

AZTherapies is an advanced clinical-stage biopharmaceutical company developing novel small molecules and biologic therapies intended to change neurodegenerative disease progression. Its lead candidate, ALZT-OP1, employs a multi-modal approach that targets neuroinflammation; the Phase 3 COGNITE trial in early Alzheimer’s disease is fully enrolled. The company expected trial completion in late 2020 with results anticipated in the first quarter of 2021. After the lead program, AZTherapies is advancing candidates for ALS and post-ischemic stroke cognitive impairment and is pursuing an innovative CAR-Treg program with potential broad application across neurodegenerative diseases. On the financing side, the company recently closed a $33.6M Series C-1 financing and earlier this year received $11.2M from a Series C Preferred Stock financing that raised aggregate gross proceeds of $37.5M. The company is led by Chairman and CEO David R. Elmaleh, Ph.D. AZTherapies' lead candidate is ALZT-OP1, a multi-modal therapy built on targeting neuroinflammation and microglia to slow or stop neurodegeneration. The company has a fully enrolled pivotal Phase 3 trial, COGNITE, being conducted under a Special Protocol Assessment with the U.S. FDA. Proceeds from the recent financing are intended to fund completion of COGNITE and ALZT-OP1 pre-commercial efforts. AZTherapies is also advancing a broader pipeline, including AZT-101, which the company plans to move into a Phase 2 trial for post-ischemic stroke cognitive impairment and a Phase 1/2a trial in ALS. The company is privately held and headquartered in Boston, Massachusetts. Management highlighted the financing will support completing the Phase 3 trial by the end of 2020 and continued pipeline advancement.

Participated · Series A · Apr 2019

BetterPT operates a digital marketplace and healthcare technology platform connecting physical therapists (PTs), patients, and physicians, offering inbound patient management (IPM) and appointment-request functionality. Its interoperable, HIPAA-compliant application is EMR compatible and aims to improve patient access to PT and clinical rehabilitation services. The company markets itself as the fastest growing specialized PT marketplace in the U.S. and partners with Hospital for Special Surgery (HSS). BetterPT’s platform lets patients find local clinics that accept their insurance and request appointments online, while providing operational efficiencies to clinics. The company recently completed a $5 million Series A financing to support growth and broader adoption of its marketplace.